180 related articles for article (PubMed ID: 23319690)
21. Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma.
Sun Y; Sun B; Wang J; Cai W; Zhao X; Zhang S; Hao X
Cancer Sci; 2009 Jun; 100(6):1018-25. PubMed ID: 19385976
[TBL] [Abstract][Full Text] [Related]
22. Investigation of IGF2, Hedgehog and fusion gene expression profiles in pediatric sarcomas.
de Souza RR; Oliveira ID; del Giúdice Paniago M; Yaoita FH; Caran EM; Macedo CR; Petrilli AS; Abib Sde C; de Seixas Alves MT; de Toledo SR
Growth Horm IGF Res; 2014 Aug; 24(4):130-6. PubMed ID: 24846856
[TBL] [Abstract][Full Text] [Related]
23. Molecular alterations of monophasic synovial sarcoma: loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity.
Pazzaglia L; Benassi MS; Ragazzini P; Gamberi G; Ponticelli F; Chiechi A; Hattinger CM; Morandi L; Alberghini M; Zanella L; Picci P; Mercuri M
Histol Histopathol; 2006 Feb; 21(2):187-95. PubMed ID: 16329043
[TBL] [Abstract][Full Text] [Related]
24. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
Korshunov A; Remke M; Werft W; Benner A; Ryzhova M; Witt H; Sturm D; Wittmann A; Schöttler A; Felsberg J; Reifenberger G; Rutkowski S; Scheurlen W; Kulozik AE; von Deimling A; Lichter P; Pfister SM
J Clin Oncol; 2010 Jun; 28(18):3054-60. PubMed ID: 20479417
[TBL] [Abstract][Full Text] [Related]
25. Gene expression profiling of synovial sarcoma: distinct signature of poorly differentiated type.
Nakayama R; Mitani S; Nakagawa T; Hasegawa T; Kawai A; Morioka H; Yabe H; Toyama Y; Ogose A; Toguchida J; Nakayama T; Yoshida T; Ichikawa H
Am J Surg Pathol; 2010 Nov; 34(11):1599-607. PubMed ID: 20975339
[TBL] [Abstract][Full Text] [Related]
26. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
Thomas DG; Giordano TJ; Sanders D; Biermann S; Sondak VK; Trent JC; Yu D; Pollock RE; Baker L
Cancer; 2005 Feb; 103(4):830-8. PubMed ID: 15641030
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of dual-color break-apart chromogenic in situ hybridization for the detection of rearranged SS18 in formalin-fixed, paraffin-embedded synovial sarcoma.
Motoi T; Kumagai A; Tsuji K; Imamura T; Fukusato T
Hum Pathol; 2010 Oct; 41(10):1397-404. PubMed ID: 20594581
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential mutations and genomic alterations in the epithelial and spindle cell components of biphasic synovial sarcomas using a human exome SNP chip.
Qi Y; Wang N; Pang LJ; Zou H; Hu JM; Zhao J; Zhang J; Liu CX; Zhang WJ; Yuan XL; Li F
BMC Med Genomics; 2015 Oct; 8():69. PubMed ID: 26503545
[TBL] [Abstract][Full Text] [Related]
29. Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study.
O'Sullivan MJ; Kyriakos M; Zhu X; Wick MR; Swanson PE; Dehner LP; Humphrey PA; Pfeifer JD
Mod Pathol; 2000 Nov; 13(11):1253-63. PubMed ID: 11106084
[TBL] [Abstract][Full Text] [Related]
30. [Detection of SYT-SSX fusion gene in paraffin-embedded tissues and its clinicopathologic significance for synovial sarcoma].
Wei Y; Sun M; Zhu H; Xu Z; Wang J; Zhu X
Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):426-30. PubMed ID: 11866984
[TBL] [Abstract][Full Text] [Related]
31. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
[TBL] [Abstract][Full Text] [Related]
32. TLE1 is a robust diagnostic biomarker for synovial sarcomas and correlates with t(X;18): analysis of 319 cases.
Knösel T; Heretsch S; Altendorf-Hofmann A; Richter P; Katenkamp K; Katenkamp D; Berndt A; Petersen I
Eur J Cancer; 2010 Apr; 46(6):1170-6. PubMed ID: 20189377
[TBL] [Abstract][Full Text] [Related]
33. AZGP1 inhibits soft tissue sarcoma cells invasion and migration.
Liu J; Han H; Fan Z; El Beaino M; Fang Z; Li S; Ji J
BMC Cancer; 2018 Jan; 18(1):89. PubMed ID: 29357838
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray.
Nagayama S; Katagiri T; Tsunoda T; Hosaka T; Nakashima Y; Araki N; Kusuzaki K; Nakayama T; Tsuboyama T; Nakamura T; Imamura M; Nakamura Y; Toguchida J
Cancer Res; 2002 Oct; 62(20):5859-66. PubMed ID: 12384549
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
36. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma.
Fernebro J; Francis P; Edén P; Borg A; Panagopoulos I; Mertens F; Vallon-Christersson J; Akerman M; Rydholm A; Bauer HC; Mandahl N; Nilbert M
Int J Cancer; 2006 Mar; 118(5):1165-72. PubMed ID: 16152617
[TBL] [Abstract][Full Text] [Related]
38. The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms.
Lesluyes T; Delespaul L; Coindre JM; Chibon F
Sci Rep; 2017 Jul; 7(1):5480. PubMed ID: 28710396
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Impact and Functional Annotations of KIF11 and KIF14 Expression in Patients with Colorectal Cancer.
Neska-Długosz I; Buchholz K; Durślewicz J; Gagat M; Grzanka D; Tojek K; Klimaszewska-Wiśniewska A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575892
[TBL] [Abstract][Full Text] [Related]
40. CINSARC signature as a prognostic marker for clinical outcome in sarcomas and beyond.
Chibon F; Lesluyes T; Valentin T; Le Guellec S
Genes Chromosomes Cancer; 2019 Feb; 58(2):124-129. PubMed ID: 30387235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
